FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

19587611000001103: Viramune 400mg modified-release tablets (Boehringer Ingelheim Ltd) 30 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 16-Nov 2011. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
66304101000001118 Viramune 400mg modified-release tablets (Boehringer Ingelheim Ltd) 30 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
66304201000001113 Viramune 400mg modified-release tablets (Boehringer Ingelheim Ltd) 30 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Viramune 400mg modified-release tablets (Boehringer Ingelheim Ltd) 30 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Viramune 400mg modified-release tablets (Boehringer Ingelheim Ltd) 30 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Viramune 400mg modified-release tablets (Boehringer Ingelheim Ltd) 30 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Viramune 400mg modified-release tablets (Boehringer Ingelheim Ltd) 30 tablet Is a Nevirapine 400mg modified-release tablets 30 tablet true Inferred relationship Existential restriction modifier
Viramune 400mg modified-release tablets (Boehringer Ingelheim Ltd) 30 tablet Has AMP Viramune 400mg modified-release tablets (Boehringer Ingelheim Ltd) true Inferred relationship Existential restriction modifier
Viramune 400mg modified-release tablets (Boehringer Ingelheim Ltd) 30 tablet Has excipient Lactose false Inferred relationship Existential restriction modifier
Viramune 400mg modified-release tablets (Boehringer Ingelheim Ltd) 30 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Viramune 400mg modified-release tablets (Boehringer Ingelheim Ltd) 30 tablet Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
Viramune 400mg modified-release tablets (Boehringer Ingelheim Ltd) 30 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Viramune 400mg modified-release tablets (Boehringer Ingelheim Ltd) 30 tablet Has specific active ingredient Nevirapine true Inferred relationship Existential restriction modifier
Viramune 400mg modified-release tablets (Boehringer Ingelheim Ltd) 30 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Viramune 400mg modified-release tablets (Boehringer Ingelheim Ltd) 30 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Viramune 400mg modified-release tablets (Boehringer Ingelheim Ltd) 30 tablet Has dispensed dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Viramune 400mg modified-release tablets (Boehringer Ingelheim Ltd) 30 tablet Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start